Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002069 |
---|---|
Receipt number | R000002370 |
Scientific Title | HLA-haploidentical allogeneic stem cell transplantation for refractory hematopoietic diseases |
Date of disclosure of the study information | 2009/06/12 |
Last modified on | 2016/03/28 09:43:22 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/06/11 15:48:40 | ||
2 | Update | 2009/06/17 15:42:51 | Recruitment status Date of protocol fixation |
|
3 | Update | 2009/11/02 13:31:12 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
4 | Update | 2009/11/02 13:32:16 | Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2009/11/02 13:33:07 | Recruitment status |
|
6 | Update | 2010/08/13 18:06:30 | UMIN ID1 |
|
7 | Update | 2010/08/16 12:31:11 | Key exclusion criteria |
|
8 | Update | 2010/09/27 15:27:09 | Interventions/Control_1 Interventions/Control_1 |
|
9 | Update | 2010/09/27 15:43:40 | Interventions/Control_1 Interventions/Control_1 |
|
10 | Update | 2011/04/07 17:49:53 | Name of person sending information Organization Division name Address |
|
11 | Update | 2011/04/07 17:51:34 | Anticipated trial start date |
|
12 | Update | 2011/04/11 10:33:14 | Key exclusion criteria Key exclusion criteria |
|
13 | Update | 2011/05/12 18:30:20 | Last follow-up date |
|
14 | Update | 2012/06/13 19:13:02 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
15 | Update | 2012/06/13 19:22:31 | Narrative objectives1 Narrative objectives1 |
|
16 | Update | 2012/06/13 19:57:08 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria |
|
17 | Update | 2013/09/19 17:59:22 | ||
18 | Update | 2013/09/19 18:01:02 | TEL TEL |
|
19 | Update | 2013/09/19 18:01:44 | Recruitment status Anticipated trial start date |
|
20 | Update | 2015/04/14 16:57:59 | Last follow-up date |
|
21 | Update | 2016/03/28 09:43:22 | Recruitment status Publication of results |